TERN
Price
$5.90
Change
-$0.25 (-4.07%)
Updated
May 17, 6:59 PM EST
79 days until earnings call
TRVI
Price
$2.77
Change
-$0.07 (-2.46%)
Updated
May 17, 6:59 PM EST
81 days until earnings call
Ad is loading...

TERN vs TRVI

Header iconTERN vs TRVI Comparison
Open Charts TERN vs TRVIBanner chart's image
Terns Pharmaceuticals
Price$5.90
Change-$0.25 (-4.07%)
Volume$223.94K
CapitalizationN/A
Trevi Therapeutics
Price$2.77
Change-$0.07 (-2.46%)
Volume$47.82K
CapitalizationN/A
View a ticker or compare two or three
TERN vs TRVI Comparison Chart

Loading...

TERNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TRVIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
TERN vs. TRVI commentary
May 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TERN is a Hold and TRVI is a StrongSell.

COMPARISON
Comparison
May 19, 2024
Stock price -- (TERN: $5.90 vs. TRVI: $2.77)
Brand notoriety: TERN and TRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TERN: 46% vs. TRVI: 29%
Market capitalization -- TERN: $381.6M vs. TRVI: $195.11M
TERN [@Biotechnology] is valued at $381.6M. TRVI’s [@Biotechnology] market capitalization is $195.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $586.12B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TERN’s FA Score shows that 0 FA rating(s) are green whileTRVI’s FA Score has 0 green FA rating(s).

  • TERN’s FA Score: 0 green, 5 red.
  • TRVI’s FA Score: 0 green, 5 red.
According to our system of comparison, TRVI is a better buy in the long-term than TERN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TERN’s TA Score shows that 6 TA indicator(s) are bullish while TRVI’s TA Score has 1 bullish TA indicator(s).

  • TERN’s TA Score: 6 bullish, 4 bearish.
  • TRVI’s TA Score: 1 bullish, 7 bearish.
According to our system of comparison, TERN is a better buy in the short-term than TRVI.

Price Growth

TERN (@Biotechnology) experienced а +6.12% price change this week, while TRVI (@Biotechnology) price change was +1.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.41%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was +60.72%.

Reported Earning Dates

TERN is expected to report earnings on Aug 06, 2024.

TRVI is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Biotechnology (+1.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for TERN with price predictions.
OPEN
A.I.dvisor published
a Summary for TRVI with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
TERN($382M) has a higher market cap than TRVI($195M). TRVI YTD gains are higher at: 106.716 vs. TERN (-9.091).
TERNTRVITERN / TRVI
Capitalization382M195M196%
EBITDAN/AN/A-
Gain YTD-9.091106.716-9%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
TERNTRVI
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 17 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Ad is loading...
TERNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TRVIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CPOCX10.820.11
+1.03%
Morgan Stanley Insight L
MPLAX13.250.01
+0.08%
Praxis International Index A
RPMVX17.540.01
+0.06%
Reinhart Mid Cap PMV Adv
RYREX36.98-0.01
-0.03%
Rydex Real Estate A
FACDX61.95-0.11
-0.18%
Fidelity Advisor Health Care A

TRVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRVI has been loosely correlated with ATNM. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if TRVI jumps, then ATNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRVI
1D Price
Change %
TRVI100%
-2.46%
ATNM - TRVI
36%
Loosely correlated
-0.51%
TRDA - TRVI
36%
Loosely correlated
+0.27%
TERN - TRVI
32%
Poorly correlated
-3.91%
CMPX - TRVI
30%
Poorly correlated
N/A
SCPH - TRVI
29%
Poorly correlated
-1.55%
More